# Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment

> **NCT00359177** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Vomiting

## Interventions

- **DRUG:** GW679769

## Key facts

- **NCT ID:** NCT00359177
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12-01
- **Primary completion:** 2006-10-12
- **Final completion:** 2006-10-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359177, "Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00359177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*